Dec 7th 2021- FDA approved DARE BIOSCIENCES INC, new drug: DARE-BV1 for bacterial vaginosis. DARE -BV1 is a thermosetting bioadhesive hydrogel containing clindamycin phosphate 2% designed as a one time vaginally-administered treatment for bacteria vaginosis. Cure rate 81%% for Dare BV-1
Current FDA- approved products have clinical cure rates of 37% -68%%
Healthcare sector for women is very strong. Medicine to better the lives of more than 21 million women affected by bacteria vaginosis!!
Dare Biosciences Inc.
Nasdaq: DARE $1.95 ish....cheap!!!
Share with friends and other social media outlets!!
Great news this week!!
0 nhận xét:
Đăng nhận xét